| Year |
Citation |
Score |
| 2022 |
Kabbani M, Michailidis E, Steensels S, Fulmer CG, Luna JM, Le Pen J, Tardelli M, Razooky B, Ricardo-Lax I, Zou C, Zeck B, Stenzel AF, Quirk C, Foquet L, Ashbrook AW, ... ... Cohen DE, et al. Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice. Cell Reports. 40: 111321. PMID 36103835 DOI: 10.1016/j.celrep.2022.111321 |
0.62 |
|
| 2017 |
Ersoy BA, Maner-Smith KM, Li Y, Alpertunga I, Cohen DE. Thioesterase-mediated control of cellular calcium homeostasis enables hepatic ER stress. The Journal of Clinical Investigation. PMID 29202465 DOI: 10.1172/Jci93123 |
0.633 |
|
| 2014 |
Kawano Y, Ersoy BA, Li Y, Nishiumi S, Yoshida M, Cohen DE. Thioesterase superfamily member 2 (Them2) and phosphatidylcholine transfer protein (PC-TP) interact to promote fatty acid oxidation and control glucose utilization. Molecular and Cellular Biology. 34: 2396-408. PMID 24732803 DOI: 10.1128/Mcb.01601-13 |
0.652 |
|
| 2013 |
Ersoy BA, Tarun A, D'Aquino K, Hancer NJ, Ukomadu C, White MF, Michel T, Manning BD, Cohen DE. Phosphatidylcholine transfer protein interacts with thioesterase superfamily member 2 to attenuate insulin signaling. Science Signaling. 6: ra64. PMID 23901139 DOI: 10.1126/Scisignal.2004111 |
0.648 |
|
| 2011 |
Shishova EY, Stoll JM, Ersoy BA, Shrestha S, Scapa EF, Li Y, Niepel MW, Su Y, Jelicks LA, Stahl GL, Glicksman MA, Gutierrez-Juarez R, Cuny GD, Cohen DE. Genetic ablation or chemical inhibition of phosphatidylcholine transfer protein attenuates diet-induced hepatic glucose production. Hepatology (Baltimore, Md.). 54: 664-74. PMID 21538437 DOI: 10.1002/Hep.24393 |
0.649 |
|
| Show low-probability matches. |